Patent · US Expired

Benzophenothiazine and benzoporphyrin dye combination photodynamic therapy of tumors

US5952329A · kind A · utility

22Cited by
1References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 23, 1997
Grant dateSep 14, 1999
Priority date
Expiry dateJan 23, 2017

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of ablating the growth of or eradicating neoplasms in mammals by PA1 (a) contacting the cells of the neoplasm with an effective amount of a combination of photoactive chromophores, and PA1 (b) exposing the chromophore-contacted neoplastic cells to light with a wavelength or wavelengths predetermined to be absorbed by the chromophores, the light also having a predetermined power density and energy level.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.